WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010115606) HUMAN MONOCLONAL ANTIBODY SPECIFIC FOR LIPOPOLYSACCARIDES (LPS) OF SEROTYPE IATS 01 OF PSEUDOMONAS AERUGINOSA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/115606    International Application No.:    PCT/EP2010/002158
Publication Date: 14.10.2010 International Filing Date: 06.04.2010
IPC:
C07K 16/12 (2006.01)
Applicants: KENTA BIOTECH AG [CH/CH]; Rehhagstrasse 79 CH-3018 Bern (CH) (For All Designated States Except US).
RUDOLF, Michael [CH/CH]; (CH) (For US Only).
KOCH, Holger [CH/CH]; (CH) (For US Only).
FAS, Stefanie [CH/CH]; (CH) (For US Only)
Inventors: RUDOLF, Michael; (CH).
KOCH, Holger; (CH).
FAS, Stefanie; (CH)
Agent: VOGELSANG-WENKE, Heike; Grünecker, Kinkeldey, Stockmair & Schwanhäusser Leopoldstraße 4 80802 München (DE)
Priority Data:
09005245.7 09.04.2009 EP
Title (EN) HUMAN MONOCLONAL ANTIBODY SPECIFIC FOR LIPOPOLYSACCARIDES (LPS) OF SEROTYPE IATS 01 OF PSEUDOMONAS AERUGINOSA
(FR) ANTICORPS MONOCLONAL HUMAIN SPÉCIFIQUE DES LIPOPOLYSACCARIDES (LPS) DE SÉROTYPE IATS 01 DE PSEUDOMONAS AERUGINOSA
Abstract: front page image
(EN)The present invention relates to a human monoclonal antibody specific for the serotype IATS 01 of P. aeruginosa, and a hybridoma producing said monoclonal antibody. In addition, the present invention relates to pharmaceutical compositions comprising at least one antibody or at least one nucleic acid encoding said antibody.
(FR)La présente invention concerne un anticorps monoclonal humain spécifique du sérotype IATS 01 de P. aeruginosa, et un hybridome produisant ledit anticorps monoclonal. De plus, la présente invention concerne des compositions pharmaceutiques comprenant au moins un anticorps ou au moins un acide nucléique codant pour ledit anticorps.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)